Viagra-like pill slows Alzheimer's decline in global study
A new medication mimicking Viagra can reduce cognitive loss in Alzheimer's patients by nearly one third, based on a worldwide study.
During a stage three trial across thirteen nations, researchers discovered the tablet AR1001 reduced decline by 31% in early cases without other treatments. This specific group showed clear improvement in their mental function over time.
The South Korean firm AriBio noted the drug helped 604 individuals taking no other medications. However, those already on other drugs did not show statistically significant results in this wider group of patients. The drug acts by boosting blood flow and stimulating brain cell pathways for memory.
Professor Tara Spires-Jones stated the drug likely directly stimulates brain cell routes that support learning and recall. She described the findings as very promising for future patient care in this challenging field. Her comments highlight the potential for better cognitive outcomes.
Dr Richard Oakley noted the drug slowed memory and thinking decline by nearly a third while side effects remained mostly mild to moderate. He emphasized this novel approach tackles underlying causes rather than just symptoms for the condition.

